Allogeneic Bone Marrow–Derived Mesenchymal Stem Cell Safety in Idiopathic Parkinson's Disease-Reference-Cited by-同舟云学术

Allogeneic Bone Marrow–Derived Mesenchymal Stem Cell Safety in Idiopathic Parkinson's Disease

Published:2021-03-27 Issue:8 Volume:36 Page:1825-1834
ISSN:0885-3185
Container-title:Movement Disorders
language:en
Short-container-title:Mov Disord

Author:

Schiess Mya¹,Suescun Jessika¹,Doursout Marie‐Francoise²,Adams Christopher¹,Green Charles³,Saltarrelli Jerome G.⁴,Savitz Sean¹,Ellmore Timothy M.⁵

Affiliation:

1. Department of Neurology, McGovern Medical School University of Texas Health Science Center at Houston Houston Texas USA

2. Department of Anesthesiology, McGovern Medical School University of Texas Health Science Center at Houston Houston Texas USA

3. Department of Pediatrics, McGovern Medical School University of Texas Health Science Center at Houston Houston Texas USA

4. Department of Surgery, McGovern Medical School University of Texas Health Science Center at Houston Houston Texas USA

5. Department of Psychology The City College of New York New York City New York USA

Funder

William and Ella Owens Medical Research Foundation

Publisher

Wiley

Subject

Clinical Neurology,Neurology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/mds.28582

Reference52 articles.

1. Neuroinflammation induces neurodegeneration;Kempuraj D;J Neurol Neurosurg Spine,2016

2. Cytokines in Parkinson's disease;Nagatsu T;J Neural Transm Suppl,2000

3. An inflammatory review of Parkinson’s disease

4. In vivo imaging of microglial activation with [11C](R)-PK11195 PET in idiopathic Parkinson's disease

5. Infiltration of CD4+ lymphocytes into the brain contributes to neurodegeneration in a mouse model of Parkinson disease;Brochard V;J Clin Invest,2009

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Microfluidics-enabled mesenchymal stem cell derived Neuron like cell membrane coated nanoparticles inhibit inflammation and apoptosis for Parkinson’s Disease;Journal of Nanobiotechnology;2024-06-25

2. Phase 1 study of safety and preliminary efficacy of intranasal transplantation of human neural stem cells (ANGE-S003) in Parkinson’s disease;Journal of Neurology, Neurosurgery & Psychiatry;2024-05-09

3. Efficacy and efficacy-influencing factors of stem cell transplantation on patients with Parkinson’s disease: a systematic review and meta-analysis;Frontiers in Neurology;2024-04-12

4. Comparing the effect of intravenous versus intracranial grafting of mesenchymal stem cells against parkinsonism in a rat model: Behavioral, biochemical, pathological and immunohistochemical studies;PLOS ONE;2024-02-13

5. Bone Marrow-Derived Stromal Stem Cells as Tools of Cellular Therapy;Comprehensive Hematology and Stem Cell Research;2024